# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-014497
Filing Date
2022-04-14
Accepted
2022-04-14 17:03:04
Documents
5
Period of Report
2022-06-01

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | etnb-def14a_20220601.htm | DEF 14A | 860388
2 | GRAPHIC | guwg5sow2cxn000004.jpg | GRAPHIC | 570597
3 | GRAPHIC | guwg5sow2cxn000003.jpg | GRAPHIC | 427806
4 | GRAPHIC | guwg5sow2cxn000001.jpg | GRAPHIC | 9604
5 | GRAPHIC | guwg5sow2cxn000002.jpg | GRAPHIC | 9604
| Complete submission text file | 0001564590-22-014497.txt |  | 2263348

Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39122 | Film No.: 22828092
SIC: 2834 Pharmaceutical Preparations